IRIDEX Stock

IRIDEX EBIT

The EBIT of IRIDEX (IRIX) as of Jul 31, 2026 is -2.57 M USD. In the previous year, EBIT was -8.30 M USD — a change of -69.03% (higher).

EBIT

-2.57 MUSD

YoY

-69.03%

Last updated:

In 2026, IRIDEX's EBIT was -2.57 M USD, a -69.03% increase from the -8.30 M USD EBIT recorded in the previous year.

The IRIDEX EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2021
-7.53 base
Jan 1, 2022
-7.54 base
Jan 1, 2023
-10.01 base
Jan 1, 2024
-8.30 base
Jan 1, 2025
-2.57 base
Jan 1, 2026 (e)
-7.16 base
Jan 1, 2027 (e)
-7.66 base
Jan 1, 2028 (e)
-8.11 base
YEAREBIT (M USD)
2028 est -8.11
2027 est -7.66
2026 est -7.16
2025 -2.57
2024 -8.30
2023 -10.01
2022 -7.54
2021 -7.53
2020 -6.58
2019 -8.97
2018 -12.87
2017 -12.89
2016 -2.57
2015 0.29
2014 2.59
2013 2.63
2012 -0.86
2011 1.93
2010 2.80
2009 2.52
2008 -7.54
2007 -24.12
2006 -4.77
Access this data via the Eulerpool API

IRIDEX Revenue

IRIDEX Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
53.90 M USD
-7.53 M USD
-5.23 M USD
Jan 1, 2022
56.97 M USD
-7.54 M USD
-7.55 M USD
Jan 1, 2023
51.87 M USD
-10.01 M USD
-9.57 M USD
Jan 1, 2024
48.67 M USD
-8.30 M USD
-8.91 M USD
Jan 1, 2025
52.68 M USD
-2.57 M USD
-4.44 M USD
Jan 1, 2026 (e)
53.00 M USD
-7.16 M USD
-859,500.05 USD
Jan 1, 2027 (e)
56.77 M USD
-7.66 M USD
343,800.00 USD
Jan 1, 2028 (e)
60.09 M USD
-8.11 M USD
1.20 M USD

IRIDEX Margins

IRIDEX stock margins

The IRIDEX margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IRIDEX. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IRIDEX.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
42.36 %
-13.98 %
-9.69 %
Jan 1, 2022
44.53 %
-13.24 %
-13.25 %
Jan 1, 2023
42.04 %
-19.29 %
-18.45 %
Jan 1, 2024
40.07 %
-17.06 %
-18.31 %
Jan 1, 2025
36.65 %
-4.88 %
-8.42 %
Jan 1, 2026 (e)
36.65 %
-13.50 %
-1.62 %
Jan 1, 2027 (e)
36.65 %
-13.50 %
0.61 %
Jan 1, 2028 (e)
36.65 %
-13.50 %
2.00 %

IRIDEX Stock analysis

What does IRIDEX do? IRIDEX Corp is a global medical technology company that specializes in the development, manufacturing, marketing, and distribution of innovative laser-based medical devices and services. The company was originally founded in 1989 and is headquartered in Mountain View, California. IRIDEX's business model is divided into various divisions, each serving different markets. The divisions include ophthalmology, otolaryngology (ENT), gynecology and urology, as well as scientific research. The company offers a wide range of high-tech laser systems that can be used to treat various conditions, such as retinal diseases, glaucoma, nasal and throat disorders, gynecological and urological conditions, and other medical applications. One of the most well-known divisions of IRIDEX is ophthalmology, which offers a wide range of laser systems for the treatment of retinal diseases. These retinal diseases include diabetic retinopathy, retinal edema, age-related macular degeneration, and retinal detachment. The company also has a high-tech system called Cyclo G6TM, which is used for the treatment of glaucoma. This system can also be used in conjunction with other devices, such as ultrasound systems, for optimized clinical effectiveness. The ENT division offers laser systems for the treatment of nasal and throat disorders, such as snoring, polyps, stenosis, and tumors. The range of laser systems varies from simple systems to advanced systems that can be connected to a flexible endoscope for more precise treatment. IRIDEX's gynecology and urology division offers laser systems for various applications, such as urinary incontinence, bladder problems, tumor removal, prostate tissue removal, and medical treatments to improve sexual function. Laser systems can also be used in combination with other medical devices, such as ultrasound systems. The company places great emphasis on scientific research and development to create and introduce innovative technologies to the market. Therefore, IRIDEX collaborates closely with various research institutes, universities, and medical professionals to further develop its technological advances. The company is also committed to providing comprehensive training and support to its customers to ensure that they use the devices safely and effectively. Overall, IRIDEX Corp has established itself as an innovative and powerful multinational company in the field of medical technology. The company is constantly striving to expand its range of products and services and impress its customers with its high-quality solutions. IRIDEX is confident that it will continue to play a significant role in the medical technology industry in the future. IRIDEX is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing IRIDEX's EBIT

IRIDEX's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of IRIDEX's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

IRIDEX's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in IRIDEX’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about IRIDEX stock

EBIT of IRIDEX is -2.57 M USD in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — IRIDEX

All Key Metrics — IRIDEX